| 000 | 01893 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518052530.0 | ||
| 264 | 0 | _c20200527 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1433-7339 | ||
| 024 | 7 |
_a10.1007/s00520-019-05006-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAjewole, Veronica B | |
| 245 | 0 | 0 |
_aIncidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study. _h[electronic resource] |
| 260 |
_bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _cApr 2020 |
||
| 300 |
_a1901-1912 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xetiology |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 700 | 1 | _aCox, James E | |
| 700 | 1 | _aSwan, Joshua T | |
| 700 | 1 | _aChikermane, Soumya G | |
| 700 | 1 | _aLamoth, Beverly | |
| 700 | 1 | _aIso, Tomona | |
| 700 | 1 | _aOkolo, Laura O | |
| 700 | 1 | _aFord, Christen L | |
| 700 | 1 | _aSchneider, Amy M | |
| 700 | 1 | _aHobaugh, Eleanor C | |
| 700 | 1 | _aBaker, Kelty R | |
| 773 | 0 |
_tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _gvol. 28 _gno. 4 _gp. 1901-1912 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00520-019-05006-6 _zAvailable from publisher's website |
| 999 |
_c29953373 _d29953373 |
||